Swiss National Bank Bridge Bio Pharma, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Swiss National Bank holds 219,300 shares of BBIO stock, worth $5.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

219,300

Previous 216,900 1.11%

Holding current value

$5.1 Million

Previous $5.49 Million 1.62%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$23.91 - $31.3 $57,384 - $75,120	2,400 Added 1.11%	219,300 $5.58 Million
Q2 2024 Aug 08, 2024	BUY	$23.0 - $31.04 $250,700 - $338,336	10,900 Added 5.29%	216,900 $5.49 Million
Q1 2024 May 07, 2024	BUY	$27.35 - $40.45 $817,765 - $1.21 Million	29,900 Added 16.98%	206,000 $6.37 Million
Q4 2023 Feb 06, 2024	SELL	$24.02 - $43.89 $432,360 - $790,020	-18,000 Reduced 9.27%	176,100 $7.11 Million
Q3 2023 Nov 08, 2023	BUY	$16.89 - $35.01 $38,847 - $80,523	2,300 Added 1.2%	194,100 $5.12 Million
Q2 2023 Aug 09, 2023	BUY	$13.29 - $18.01 $619,314 - $839,266	46,600 Added 32.09%	191,800 $3.3 Million
Q1 2023 May 10, 2023	SELL	$7.17 - $18.55 $114,003 - $294,945	-15,900 Reduced 9.87%	145,200 $2.41 Million
Q4 2022 Feb 08, 2023	BUY	$6.74 - $11.52 $31,004 - $52,992	4,600 Added 2.94%	161,100 $1.23 Million
Q2 2022 Aug 09, 2022	BUY	$5.21 - $12.14 $90,133 - $210,022	17,300 Added 12.43%	156,500 $1.42 Million
Q1 2022 May 09, 2022	SELL	$7.34 - $17.16 $68,262 - $159,588	-9,300 Reduced 6.26%	139,200 $1.41 Million
Q3 2021 Nov 08, 2021	BUY	$46.87 - $64.24 $37,496 - $51,391	800 Added 0.54%	148,500 $6.96 Million
Q2 2021 Aug 06, 2021	BUY	$46.47 - $63.93 $1.32 Million - $1.82 Million	28,400 Added 23.81%	147,700 $9 Million
Q1 2021 May 07, 2021	BUY	$55.47 - $72.35 $6.62 Million - $8.63 Million	119,300 New	119,300 $7.35 Million

Others Institutions Holding BBIO

# of Institutions

291

Shares Held

171M

Call Options Held

10.4M

Put Options Held

2.37M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.45B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Bridge Bio Pharma, Inc. Transaction History